The man who pioneered cancer treatment – Patrick Soon-Shiong
Patrick was born in 1952 in South Africa during the time of apartheid. His parents were Chinese immigrants who were compelled to leave their land following the Second World War. At an early age of sixteen, Patrick attained his graduation from his school. At the age of twenty-three, he attained his graduation degree from the University of Witwatersrand. He completed his internship at the Johannesburg General Hospital and acquired his Master of Science Degree from the University of British Columbia. He also happens to be the first resident to collect multiple research awards from a host of premiere institutions like the American College of Surgeons, Royal College of Physicians, Surgeons of Canada and the American Association of Academic Surgery.
He then immigrated to the USA for his surgical training at the University of California, Los Angeles. He became a member of the Medical School faculty at the UCLA as an assistant professor at a young age of 31. In 1991, he left UCLA to come with VivoRx, a diabetes research firm. He founded the American Pharmaceutical Partners in 1997 and owns around 80% of the shares. His fortune is an estimated $3.5 billion. He is currently the founder, chairman and CEO of Abraxis BioScience, a bio-technology company that is working towards the development of effective cancer treatment. This nanotech drug is believed to be extremely potent with fewer side-effects.